News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bayer AG (BAYN.DE) Eyes At Least 7.5 Billion Euros In Sales From Five Key Drugs



2/28/2014 7:25:24 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LEVERKUSEN, Germany, Feb 28 (Reuters) - Germany's largest drugmaker Bayer lifted its estimate for potential sales of new drugs by billions of euros on Friday, softening the blow of a fall in fourth-quarter earnings.

Adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) in the last three months of 2013 slipped to 1.77 billion euros, dampened by a weak Japanese yen and emerging-market currencies, the company said, missing the 1.91 billion euro average estimate in a Reuters poll.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters


comments powered by Disqus
Reuters
Bayer AG
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES